Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zengye decoction is a classic traditional Chinese medicine (TCM) herbal formula composed of Radix Scrophulariae (Xuanshen), Ophiopogon japonicus (Maidong), and Rehmannia glutinosa (Shengdihuang)[3][4][7]. Traditionally, it is used to "moisten the intestines," increase body fluids, and relieve dryness-related symptoms such as constipation, thirst, and dry tongue[1][3]. Modern research indicates that Zengye decoction exerts its effects through multiple mechanisms including modulation of aquaporin expression in the colon, regulation of gut microbiota composition and metabolism, improvement of insulin sensitivity via the Akt signaling pathway, and anti-inflammatory actions[1][2][5]. It has been studied for use in conditions such as slow transit constipation (STC), primary Sjögren’s syndrome, severe acute pancreatitis with acute kidney injury, type 2 diabetes mellitus with yin deficiency syndromes, and other dryness-related disorders[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zengye decoction.